2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis
6
Seizures
5
Marijuana Abuse
3
Lennox Gastaut Syndrome
3
Epilepsies, Myoclonic
3
Colonic Neoplasms
3
Breast Neoplasms
3
Sturge-Weber Syndrome
2
Neoplasms
2
Nausea
2
Glioblastoma
2
Anxiety Disorders
2
Vomiting
1
Tuberous Sclerosis 2
1
Tuberous Sclerosis 1
1
Spasms, Infantile
1
Solid Tumor
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Parasomnias
1
Pancreatic Neoplasms
1
Pain
1
Multiple Myeloma
1
Liver Neoplasms
1
Liver Cirrhosis
1
Gallbladder Neoplasms
1
Epilepsy
1
Dysgeusia
1
Drug Resistant Epilepsy
1
Colorectal Neoplasms
1
Interventions
Fentanyl
27
Analgesia
23
Morphine
20
Acupuncture Therapy
18
Surveys and Questionnaires
16
Oxycodone
16
Zoledronic Acid
15
Acetaminophen
14
Therapeutics
13
Radiotherapy
13
Psychiatric Rehabilitation
13
Ketamine
13
Methadone
11
Lidocaine
11
Hydromorphone
11
Bupivacaine
11
nabiximols
10
Ibandronic Acid
10
Ropivacaine
9
Early Intervention, Educational
7
Analgesics, Opioid
7
Saline Solution
6
Music Therapy
6
Cryotherapy
6
Cryosurgery
6
Yoga
5
Water
5
Tapentadol
5
Pregabalin
5
Methods
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pain
×
Cannabidiol
×
Clear all
NCT03948074
2025-09-10
CAFCARS
British Columbia Cancer Agency
Phase 2
Completed
91 enrolled